Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eytan

Showing results (21-30 of 2,003) with videos related to

Pageof 201
Sort By:
Harefuah|November 23, 2006
[Changes in the transplantation world--from altruism to a utilitarian approach]Eytan Mor
Nature Reviews. Neuroscience|February 12, 2002
Evolutionary autonomous agents: a neuroscience perspectiveEytan Ruppin
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 30, 2005
Mechanism of multidrug resistance in relation to passive membrane permeationGera D Eytan
Best Practice & Research. Clinical Haematology|November 23, 2015
IDH2 inhibition in AML: Finally progress?Eytan M Stein
Investigative Ophthalmology & Visual Science|April 28, 2004
Quantifying retinal nerve fiber layer thickness histologically: a novel approach to sectioning of the retinaEytan Z Blumenthal
Future Oncology (London, England)|December 16, 2017
Enasidenib, a targeted inhibitor of mutant IDH2 proteins for treatment of relapsed or refractory acute myeloid leukemiaEytan M Stein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2015
Molecular Pathways: IDH2 Mutations-Co-opting Cellular Metabolism for Malignant TransformationEytan M Stein
Hematology. American Society of Hematology. Education Program|December 6, 2015
Molecularly targeted therapies for acute myeloid leukemiaEytan M Stein
Annals of the New York Academy of Sciences|October 4, 2007
Applying embryo-derived immune tolerance to the treatment of immune disordersEytan R Barnea
Innovations in Pharmacy|March 18, 2024
In-class Exercises Regarding the Roles of Excipients in a Pharmaceutics CourseEytan A Klausner
Pageof 201

Showing results (21-30 of 2,003) with videos related to

Sort By:
Pageof 201
Harefuah|November 23, 2006
[Changes in the transplantation world--from altruism to a utilitarian approach]Eytan Mor
Nature Reviews. Neuroscience|February 12, 2002
Evolutionary autonomous agents: a neuroscience perspectiveEytan Ruppin
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 30, 2005
Mechanism of multidrug resistance in relation to passive membrane permeationGera D Eytan
Best Practice & Research. Clinical Haematology|November 23, 2015
IDH2 inhibition in AML: Finally progress?Eytan M Stein
Investigative Ophthalmology & Visual Science|April 28, 2004
Quantifying retinal nerve fiber layer thickness histologically: a novel approach to sectioning of the retinaEytan Z Blumenthal
Future Oncology (London, England)|December 16, 2017
Enasidenib, a targeted inhibitor of mutant IDH2 proteins for treatment of relapsed or refractory acute myeloid leukemiaEytan M Stein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2015
Molecular Pathways: IDH2 Mutations-Co-opting Cellular Metabolism for Malignant TransformationEytan M Stein
Hematology. American Society of Hematology. Education Program|December 6, 2015
Molecularly targeted therapies for acute myeloid leukemiaEytan M Stein
Annals of the New York Academy of Sciences|October 4, 2007
Applying embryo-derived immune tolerance to the treatment of immune disordersEytan R Barnea
Innovations in Pharmacy|March 18, 2024
In-class Exercises Regarding the Roles of Excipients in a Pharmaceutics CourseEytan A Klausner
Pageof 201